The chapter describes the legal regime and practices concerning a broad range of topics, including collaboration of pharmaceutical manufacturers with healthcare professionals, advertising of medicines and medical devices, infringements of competition law, issuance of marketing authorisation for medicines, determination of prices for prescription-only and over-the-counter medicines, reimbursement of the cost of medicines, and pharmacovigilance.
The chapter can be downloaded here. Reproduced with permission from Law Business Research Ltd. This article was first published in Getting the Deal Through – Life Sciences 2019 (Published: January 2019). For further information please visit www.gettingthedealthrough.com